BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,336,000 | -22.6% | 45,000 | -10.0% | 0.65% | -7.7% |
| Q4 2021 | $6,891,000 | -0.8% | 50,000 | 0.0% | 0.70% | -7.7% |
| Q3 2021 | $6,946,000 | +43.1% | 50,000 | 0.0% | 0.76% | +40.4% |
| Q2 2021 | $4,854,000 | +42.0% | 50,000 | 0.0% | 0.54% | +29.5% |
| Q1 2021 | $3,418,000 | -11.4% | 50,000 | +11.1% | 0.42% | -27.2% |
| Q4 2020 | $3,857,000 | +48.3% | 45,000 | +12.5% | 0.57% | +16.0% |
| Q3 2020 | $2,600,000 | -11.1% | 40,000 | 0.0% | 0.49% | -18.5% |
| Q2 2020 | $2,924,000 | +114.8% | 40,000 | 0.0% | 0.61% | +67.9% |
| Q1 2020 | $1,361,000 | -37.5% | 40,000 | 0.0% | 0.36% | -17.0% |
| Q4 2019 | $2,178,000 | +30.5% | 40,000 | 0.0% | 0.44% | +18.5% |
| Q3 2019 | $1,669,000 | +90.5% | 40,000 | +100.0% | 0.37% | +99.5% |
| Q2 2019 | $876,000 | – | 20,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |